This paper analyzes the asymmetry in the international relations as refers to the recognition of industrial property rights in the pharmaceutical industry. It focuses on the'/> Asymmetry in international relations, industrial property rights and anti-HIV medication
首页> 外文期刊>Ciencia e Saude Coletiva >Asymmetry in international relations, industrial property rights and anti-HIV medication
【24h】

Asymmetry in international relations, industrial property rights and anti-HIV medication

机译:国际关系,工业产权和抗艾滋病毒药物方面的不对称

获取原文
           

摘要

> size="2" face="Verdana">This paper analyzes the asymmetry in the international relations as refers to the recognition of industrial property rights in the pharmaceutical industry. It focuses on the impact of such relations upon the access to ARV medication, an issue of worldwide interest due to its connection with the development of the nations. Clashing interests and the position taken by some countries in their patent laws point to a scenario less favorable for the access of peripheral countries to anti-HIV/AIDS medication. On the other hand, it seems that the success of the Brazilian STD/AIDS program in negotiating ARV prices will open new possibilities. The solution may be the internal strengthening of the National States and the active role played by the Agencies of the United Nations System in defense of the collective human interests.
机译:> size =“ 2” face =“ Verdana”>本文分析了国际关系中的不对称性,指的是制药业对工业产权的承认。它着眼于这种关系对获得抗逆转录病毒药物的影响,由于抗逆转录病毒药物与国家的发展有关,因此引起了全世界的关注。利益冲突和某些国家在专利法中所采取的立场表明,这种情况不利于周边国家获得抗艾滋病毒/艾滋病药物。另一方面,巴西性病/艾滋病计划在抗逆转录病毒价格谈判方面的成功似乎将开辟新的可能性。解决的办法可能是加强民族国家的内部力量,以及联合国系统各机构在捍卫集体人类利益方面发挥的积极作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号